海外の治験の状況「濾胞性リンパ腫」での検索結果
130件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A phase II study of obinutuzumab monotherapy in rituximab-refractory follicular lymphoma
- rituximab refractory follicular lymphoma br>MedDRA version: 16.1 Level: LLT Classification code 10016896 Term: Follicle centre lymphoma diffuse small cell lymphoma NOS System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Netherlands
- 2014-03-26
Authorised
- Study of Nivolumab in subjects with Relapsed or Refractory Follicular Lymphoma (FL)
- Lymphoma. Non-Hodgkin MedDRA version: 17.0 Level: PT Classification code 10029547 Term: Non-Hodgkin's lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, France, Germany, Italy, Norway, Singapore, Spain, Sweden, United Kingdom, United States
- 2013-12-10
Authorised
- A Study to Compare Efficacy and Safety between CT-P10 and Rituxan in Patients with Low Tumour Burden Follicular Lymphoma
- Low Tumour Burden Follicular Lymphoma. br>MedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belarus, Brazil, Chile, Czech Republic, Georgia, India, Israel, Italy, Japan, Korea, Republic of, Latvia, Malaysia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Spain, Taiwan, Thailand, Ukraine, United Kingdom, United States
- 2015-09-24
Authorised
- A Study Comparing SAIT101 to MabThera® in Patients with Low Tumor Burden Follicular Lymphoma
- Low Tumor Burden Follicular Lymphoma (LTBFL) br>MedDRA version: 19.0 Level: HLGT Classification code 10025320 Term: Lymphomas non-Hodgkin's B-cell System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Chile, Croatia, Czech Republic, Egypt, France, Georgia, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Latvia, Mexico, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, South Africa, Spain, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2016-09-07
Authorised
- A multicenter, open-label study of INCB050465 in patients with relapsed or refractory follicular lymphoma
- Follicular Lymphoma br>MedDRA version: 20.0 Level: LLT Classification code 10067070 Term: Follicular B-cell non-Hodgkin's lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-10-17
Authorised
- A multicenter, open-label study of INCB050465 in patients with relapsed or refractory follicular lymphoma
- Follicular Lymphoma br>MedDRA version: 20.0 Level: LLT Classification code 10067070 Term: Follicular B-cell non-Hodgkin's lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Poland, Spain, Sweden, United Kingdom, United States
- 2017-10-16
Authorised
- Rituximab plus lenalidomide or rituximab monotherapy for untreated patients with follicular lymphoma in need of therapy.
- Untreated patients with follicular lymphoma in need of therapy. br>MedDRA version: 14.0 Level: PT Classification code 10025310 Term: Lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Finland, Sweden, Switzerland
- 2011-02-14
Authorised
- Phase II Study of Fractionated 90Y Ibritumomab tiuxetan (ZevalinTM) as initial therapy of Follicular Lymphoma - FIZZ Study
- Follicular lymphoma LLT Follicle centre lymphoma, follicular grade I, II, III PT Follicle centre lymphoma, follicular grade I, II, III MedDRA Version 9
- United Kingdom
- 2006-09-18
Authorised
- A Study of PCI-32765 (Ibrutinib) in Patients with Refractory Follicular Lymphoma
- Follicular Lymphoma br>MedDRA version: 18.1 Level: HLGT Classification code 10025320 Term: Lymphomas non-Hodgkin's B-cell System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, France, Germany, Italy, Poland, Russian Federation, Spain, United Kingdom, United States
- 2012-11-23
Authorised
- A Study Comparing SAIT101 to MabThera® in Patients with Low Tumor Burden Follicular Lymphoma
- Low Tumor Burden Follicular Lymphoma (LTBFL) br>MedDRA version: 20.0 Level: HLGT Classification code 10025320 Term: Lymphomas non-Hodgkin's B-cell System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Belarus, Bosnia and Herzegovina, Bulgaria, Chile, Croatia, Czech Republic, Egypt, France, Georgia, Germany, Guatemala, Hong Kong, Hungary, India, Italy, Korea, Republic of, Latvia, Mexico, Panama, Philippines, Romania, Saudi Arabia, Serbia, South Africa, Spain, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2016-07-21